Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.
Clinical trial NCT05033587 · UNKNOWN
Trial details
- NCT number
- NCT05033587
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2023-05-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.